Sign In
Buy GLMD
$0.537
-0.0232 (-4.14%)
At Close: Jul 13, 2026
Galmed Pharmaceuticals Earnings Calls
Jun 30, 2026
(Upcoming)
| Release date | Jul 30, 2026 |
| EPS estimate | -$0.390 |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Expected change | +/- 12.22% |
Mar 31, 2026
-$0.92 (-80.39%)
| Release date | Mar 31, 2026 |
| EPS estimate | -$0.510 |
| EPS actual | -$0.92 |
| EPS Surprise | -80.39% |
| Revenue estimate | 1.299M |
| Revenue actual | - |
Dec 31, 2025
-$0.80 (-56.86%)
| Release date | Mar 31, 2026 |
| EPS estimate | -$0.510 |
| EPS actual | -$0.80 |
| EPS Surprise | -56.86% |
| Revenue estimate | 1.299M |
| Revenue actual | - |
Sep 30, 2025
-$0.330 (38.89%)
| Release date | Nov 26, 2025 |
| EPS estimate | -$0.540 |
| EPS actual | -$0.330 |
| EPS Surprise | 38.89% |
| Revenue estimate | 1.371M |
| Revenue actual | - |
Last 4 Quarters for Galmed Pharmaceuticals
Below you can see how GLMD performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Sep 30, 2025
Beat
| Release date | Nov 26, 2025 |
| Price on release | $0.92 |
| EPS estimate | -$0.540 |
| EPS actual | -$0.330 |
| EPS surprise | 38.89% |
| Date | Price |
|---|---|
| Nov 20, 2025 | $0.81 |
| Nov 21, 2025 | $0.84 |
| Nov 24, 2025 | $0.85 |
| Nov 25, 2025 | $0.82 |
| Nov 26, 2025 | $0.92 |
| Nov 28, 2025 | $0.94 |
| Dec 01, 2025 | $0.97 |
| Dec 02, 2025 | $0.96 |
| Dec 03, 2025 | $1.07 |
| 4 days before | 13.36% |
| 4 days after | 15.83% |
| On release day | 1.74% |
| Change in period | 31.30% |
Dec 31, 2025
Missed
| Release date | Mar 31, 2026 |
| Price on release | $0.490 |
| EPS estimate | -$0.510 |
| EPS actual | -$0.80 |
| EPS surprise | -56.86% |
| Date | Price |
|---|---|
| Mar 25, 2026 | $0.600 |
| Mar 26, 2026 | $0.588 |
| Mar 27, 2026 | $0.505 |
| Mar 30, 2026 | $0.475 |
| Mar 31, 2026 | $0.490 |
| Apr 01, 2026 | $0.530 |
| Apr 02, 2026 | $0.540 |
| Apr 06, 2026 | $0.521 |
| Apr 07, 2026 | $0.570 |
| 4 days before | -18.33% |
| 4 days after | 16.35% |
| On release day | 8.16% |
| Change in period | -4.98% |
Mar 31, 2026
Missed
| Release date | Mar 31, 2026 |
| Price on release | $0.490 |
| EPS estimate | -$0.510 |
| EPS actual | -$0.92 |
| EPS surprise | -80.39% |
| Date | Price |
|---|---|
| Mar 25, 2026 | $0.600 |
| Mar 26, 2026 | $0.588 |
| Mar 27, 2026 | $0.505 |
| Mar 30, 2026 | $0.475 |
| Mar 31, 2026 | $0.490 |
| Apr 01, 2026 | $0.530 |
| Apr 02, 2026 | $0.540 |
| Apr 06, 2026 | $0.521 |
| Apr 07, 2026 | $0.570 |
| 4 days before | -18.33% |
| 4 days after | 16.35% |
| On release day | 8.16% |
| Change in period | -4.98% |
Jun 30, 2026
(Upcoming)
| Release date | Jul 30, 2026 |
| Price on release | - |
| EPS estimate | -$0.390 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jul 07, 2026 | $0.569 |
| Jul 08, 2026 | $0.570 |
| Jul 09, 2026 | $0.570 |
| Jul 10, 2026 | $0.560 |
| Jul 13, 2026 | $0.537 |
Galmed Pharmaceuticals Earnings History
Earnings Calendar
FAQ
When is the earnings report for GLMD?
Galmed Pharmaceuticals Ltd. (GLMD) has scheduled its earnings report for Jul 30, 2026 before the markets open.
What is the GLMD price-to-earnings (P/E) ratio?
GLMD P/E ratio as of Jul 13, 2026 (TTM) is -0.268.
What is the GLMD EPS forecast?
The forecasted EPS (Earnings Per Share) for Galmed Pharmaceuticals Ltd. (GLMD) for the first fiscal quarter 2026 is -$0.390.
What are Galmed Pharmaceuticals Ltd.'s retained earnings?
On its balance sheet, Galmed Pharmaceuticals Ltd. reported retained earnings of $0 for the latest quarter ending Mar 31, 2026.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
